were intubated and ventilated and anesthesia was maintained with inhaled isoflurane (1-2.5%).
The ischemia/perfusion (I/R) surgery was done as previously reported 3, 4 . Briefly, cut the skin along the left side of sternum, and detach the subcutaneous tissues along the inferior fringe of 3 pectoralis major muscle. Then cut the pectoralis muscle groups transversely to expose the thoracic cage. After that, enter the fourth intercostal space by blunt dissection and separate the third and fourth ribs using micro-dissecting retractors. The left anterior descending (LAD) artery is localized 1-2 mm below the junction of pulmonary infundibulum and the left atrial appendage.
We ligated the middle of LAD using a 5-0-polypropylene suture from the left border of the pulmonary conus to the right border of the left atrial appendage for 30 min. For intramyocardial injection, 5×10 5 CSCs are injected into two sites near the peri-infarct zone at 20 µl of total volume after LAD ligation (n=15). In control group, we injected the same volume of PBS solution to the mice (n=7). We monitored the mice until they are fully conscious, and then return them to their cages. During the operation, the heart rate, respiratory rate, and body temperature of the mice were carefully monitored. After surgery, buprenorphine (0.05/mg/kg, s.c.) was applied every 12 hours for 3 days for pain relief. At end of experiment, mice were sacrificed by exposure to 100% CO 2 followed by cervical dislocation, and heart samples were harvested for corresponding analyses.
Histological analysis.
Hearts from study and control groups were embedded into OCT compound (Miles Scientific). Frozen sections (5 µm thick) were processed for immunostaining. Fluor 647 (all from Invitrogen) appropriately. DAPI was used for nuclear counterstaining.
To track transdifferentation of BM-derived cells in heart, immunohistochemical staining of GFP expression was also carried out at month 12 after BMT. Briefly, the anti-GFP antibody was labeled with biotin-conjugated goat anti-rabbit IgG (Santa Cruz Biotech, Santa Cruz, CA) and the GFP expressions were detected by the color reaction with AEC (3-Amino-9-Ethylcarbazole) Substrate Kit (BD Pharmingen). To detect endothelial differentiation of BM-derived cells, CD31
staining was carried out at month 12 after BMT. Rabbit anti-GFP antibody (Invitrogen) and rat anti-mouse CD31 (BD Pharmingen) were used. And Alexa Fluor 488 and 594-conjugated secondary antibody were used. To track transdifferentation of BM-derived cells in brain, skeletal muscle, intestine, and kidney, immunohistochemical staining of GFP expression was carried out at month 12 after BMT and nucleus were counter stained with DAPI.
To track cardiomyocytes differentiation of BM-derived CSCs in hearts at week 2 after cell transplantation (n=7), rabbit anti-GFP antibody (Invitrogen) and mouse anti-α-SA antibody (Sigma) were used. Alexa Fluor 488-and Fluor 594-conjugated secondary antibodies were applied appropriately. DAPI was used for nuclear counterstaining.
Supplemental References
Figure S1. FACS analysis of GFP positive cells in heart after BMT with or without I/R injury at month 2. I/R could increase GFP + cells engraftment but not significant. Normal (n=4), IR (n=4). The results revealed that GFP+ cells were increased at month 6 compared to month 2 after BMT. Scale bar=50μm. Totally 10 hearts were harvested at month 6, and 4 hearts at month 2. Figure S4 . Endothelial differentiation of BM-derived cells. One year after BMT, BM-derived cells could differentiate into endothelial cells as confirmed by CD31 (red) and GFP (green) double staining. Cardiomyocytes were stained with α-sarcomeric actin (α-SA) (cyan) and nuclei were counter stained with DAPI (blue). Scale bar=50μm. Totally 10 hearts were harvested at month 12.
